4th Annual Gene Therapy Patient Engagement Summit
May 29 - 31, 2024
Boston, MA
Trinity Life Sciences is a proud sponsor of the 4th Annual Gene Therapy Patient Engagement Summit on May 29 – 31, 2024 in Boston, MA. Monique Marsh, Associate Director and Head of Qualitative Innovation and Implementation at Trinity Life Sciences will present on “DEI in Clinical Trials: Current Initiatives and the Impact of the FDA Guidance on Cell and Gene Therapy Trials” on Thursday, May 30 at 12 PM. Be sure to connect with Monique, Jennifer Parr and Keren Shani onsite to talk about how Trinity can help you effectively implement patient-centric gene therapy development.
Session Synopsis
- Assessment of current initiatives employed to improve clinical trial diversity
- Current challenges and barriers for patients, PIs, and life science executives
- Impact of FDA guidance on pharma and biotech organizations
- Guidance on what tactics are the most likely to be impactful to improve trial diversity
- Special considerations for ensuring cell and gene therapy trial diversity
